# A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis

> **NCT07169695** · PHASE2 · RECRUITING · sponsor: **Laboratoires Thea** · enrollment: 120 (estimated)

## Conditions studied

- Moderate to Severe Vernal Keratoconjunctivitis

## Interventions

- **DIAGNOSTIC_TEST:** Slit Lamp Examination
- **DIAGNOSTIC_TEST:** Far Best Corrected Visual Acuity (BCVA)
- **DRUG:** T1695
- **DRUG:** Ciclosporin
- **DIAGNOSTIC_TEST:** Corneal fluorescein staining score on modified Oxford scale

## Key facts

- **NCT ID:** NCT07169695
- **Lead sponsor:** Laboratoires Thea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-24
- **Primary completion:** 2027-01-21
- **Final completion:** 2027-01-21
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07169695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07169695, "A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07169695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*